• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

11.76 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,190,753
Open 11.88
Bid (Size) 11.48 (400)
Ask (Size) 12.04 (200)
Prev. Close 11.76
Today's Range 11.41 - 11.93
52wk Range 4.720 - 19.11
Shares Outstanding 122,816,314
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors
December 30, 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
3 Russell 2000 Stocks We Think Twice About
December 17, 2025
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these... 
Via StockStory

Performance

YTD
N/A
N/A
1 Month
-3.0%
-3.0%
3 Month
+29.2%
+29.2%
6 Month
+60.9%
+60.9%
1 Year
-28.7%
-28.7%

More News

Read More
News headline image
3 Stocks Under $50 We Steer Clear Of
December 16, 2025
Via StockStory
News headline image
Earnings Scheduled For October 28, 2025 ↗
October 28, 2025
Via Benzinga
News headline image
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
December 15, 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Present New ctDNA Research at SABCS 2025
December 10, 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025
December 08, 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
Testing & Diagnostics Services Stocks Q3 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)
December 05, 2025
Via StockStory
News headline image
3 Overrated Stocks That Concern Us
December 03, 2025
Via StockStory
News headline image
1 Cash-Burning Stock to Research Further and 2 We Brush Off
November 25, 2025
Via StockStory
Topics Retirement
News headline image
NeoGenomics, Fortrea, and Acadia Healthcare Shares Skyrocket, What You Need To Know
November 21, 2025
Via StockStory
Topics Artificial Intelligence Economy Stocks
News headline image
1 High-Flying Stock on Our Buy List and 2 We Find Risky
November 16, 2025
Via StockStory
News headline image
Earnings Scheduled For November 14, 2025 ↗
November 14, 2025
Via Benzinga
News headline image
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off
November 09, 2025
Via StockStory
News headline image
3 Volatile Stocks We Keep Off Our Radar
November 06, 2025
Via StockStory
News headline image
NeoGenomics to Participate in Upcoming Investor Conferences
November 06, 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
The Top 5 Analyst Questions From NeoGenomics’s Q3 Earnings Call
November 04, 2025
Via StockStory
Topics Earnings
News headline image
NeoGenomics (NEO): Buy, Sell, or Hold Post Q3 Earnings?
November 03, 2025
Via StockStory
Topics Stocks
News headline image
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
October 30, 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
NEO Q3 Deep Dive: Clinical Volume Gains and New Product Launches Shape Outlook
October 29, 2025
Via StockStory
News headline image
NeoGenomics (NEO) Q3 2025 Earnings Call Transcript ↗
October 28, 2025
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
Why NeoGenomics (NEO) Stock Is Trading Up Today
October 28, 2025
Via StockStory
Topics World Trade
News headline image
NeoGenomics Inc (NASDAQ:NEO) Surpasses Q3 Revenue Estimates as Clinical Testing Drives Growth ↗
October 28, 2025
Via Chartmill
Topics Earnings
News headline image
NeoGenomics’s (NASDAQ:NEO) Q3 Sales Top Estimates, Stock Soars
October 28, 2025
Via StockStory
News headline image
NeoGenomics Reports Third Quarter 2025 Results
October 28, 2025
From NeoGenomics, Inc.
Via Business Wire

Frequently Asked Questions

Is NeoGenomics, Inc. - Common Stock publicly traded?
Yes, NeoGenomics, Inc. - Common Stock is publicly traded.
What exchange does NeoGenomics, Inc. - Common Stock trade on?
NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeoGenomics, Inc. - Common Stock?
The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market
What is the current price of NeoGenomics, Inc. - Common Stock?
The current price of NeoGenomics, Inc. - Common Stock is 11.76
When was NeoGenomics, Inc. - Common Stock last traded?
The last trade of NeoGenomics, Inc. - Common Stock was at 01/02/26 04:00 PM ET
What is the market capitalization of NeoGenomics, Inc. - Common Stock?
The market capitalization of NeoGenomics, Inc. - Common Stock is 1.44B
How many shares of NeoGenomics, Inc. - Common Stock are outstanding?
NeoGenomics, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap